跳至主要内容
临床试验/KCT0005531
KCT0005531尚未招募未知

Improvement of lower urinary tract symptoms and incidence of retrograde ejaculation when 2.5mg or 5mg of Terazosin is administered to patients with benign prostatic hyperplaisa

Pusan National University Hospital0 个研究点目标入组 142 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
142

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
Male

入选标准

  • 1) Adult male over 19 years old
  • 2) Those with an IPSS total score of 8 or more
  • 3) Those with a maximum urine velocity (Qmax) of less than 10mL/s
  • 4) Those who agreed to participate in this study by handwriting

排除标准

  • 1) Those who are hypersensitive to a-blocker drugs
  • 2) Those with bladder neck stenosis or urinary tract stenosis
  • 3) Those with renal dysfunction (serum creatine concentration>2.0mg/dL)
  • 4) Those with severe liver disorder or medical history
  • 5) Those with severe cardiovascular disease
  • 6) Those with severe low blood pressure
  • 7) Others who are inadequate to participate in this research as the research director judges

研究者

相似试验